Back مركز غاماليا الوطني لأبحاث علوم الأوبئة والأحياء الدقيقة Arabic Почётлы академик Н. Ф. Гамалея исемендәге эпидемиология һәм микробиология Милли тикшеренеү үҙәге Bashkir Institut Gamaleia de Recerca en Epidemiologia i Microbiologia Catalan Gamaleja-Institut für Epidemiologie und Mikrobiologie German Ερευνητικό Ινστιτούτο Επιδημιολογίας και Μικροβιολογίας Γκαμαλέγια Greek Centro Nacional de Investigación de Epidemiología y Microbiología Gamaleya Spanish مؤسسه تحقیقات همه‌گیرشناسی و میکروبیولوژی گامالیا Persian Gamalejan mikrobiologian ja epidemologian tutkimusinstituutti Finnish Institut de recherche Gamaleïa d'épidémiologie et de microbiologie French מרכז המחקר הלאומי לחקר מגיפות ומיקרוביולוגיה HE

Gamaleya Research Institute of Epidemiology and Microbiology

55°48′06″N 37°27′27″E / 55.8017°N 37.4576°E / 55.8017; 37.4576

Gamaleya Research Institute of Epidemiology and Microbiology
Formation1891 (1891) (as N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology)
FounderFilipp Blymenthal[1]
PurposeFund vaccine development
Headquarters18 Gamaleya Street
Moscow, Russia 123098
Director General
Alexander Gintsburg
Parent organization
Ministry of Health of the Russian Federation
Staff
379 (including 92 professors)[2][3]
Websitegamaleya.org (in Russian)
gamaleya.org/en(in English)

The Gamaleya Research Institute of Epidemiology and Microbiology,[note 1] previously the N. F. Gamaleya Federal Research Center for Epidemiology & Microbiology, is a Russian medical-research institute within the Ministry of Health of the Russian Federation.[note 2]

Founded in 1891 by Filipp Markovich Blyumental,[4] it is named after Soviet scientist Nikolay Fyodorovich Gamaleya (1859–1949), famed as a pioneer in microbiology and in vaccine research. The institute is best known internationally for developing the earliest vaccine for SARS-CoV-2, in collaboration with the 48th Central Research Institute of the Ministry of Defence and the Vector Institute of the Rospotrebnadzor, in response to the COVID-19 pandemic.[5][6]

  1. ^ - "BLJUMENTAL', Filipp Markovič [...] 1891-1917 [:] Gründer und Direktor des privaten „Chemisch-Mikroskopischen und Bakteriologischen Kabinetts“ bzw. „Chemisch-Bakteriologischen Instituts von Dr. Philipp Blumenthal“ [...] in Moskau [...]." drw.saw-leipzig.de
  2. ^ Национальный исследовательский центр эпидемиологии и микробиологии имени почётного академика Н. Ф. Гамалеи, основанный в 1891 году, является ведущим в своей сфере исследовательским учреждением в мире. (tr. "The National Research Center for Epidemiology and Microbiology named after Honorary Academician N.F. Gamaleya, founded in 1891, is a leading research institution in the world") gamaleya.org, accessed 23 June 2021
  3. ^ "НИЦЭМ им. Н. Ф. Гамалеи". gamaleya.org.
  4. ^ "1891 г.[:] Частный химико-микроскопический и бактериологический кабинет Ф.М. Блюменталя." (tr. "1891 [:] Private chemical-microscopic and bacteriological study of FM Blumenthal.") gamaleya.org
  5. ^ "COVID-19 vaccines by Gamaleya Center, Vektor are most promising". TASS. Retrieved 11 August 2020.
  6. ^ "Russia's COVID-19 vaccine successfully completes first phase of human clinical trials - Health News, Firstpost". Firstpost. 13 July 2020. Retrieved 11 August 2020.


Cite error: There are <ref group=note> tags on this page, but the references will not show without a {{reflist|group=note}} template (see the help page).

Rich TVX News Network Site

Rich TVX News Network Info

© MMXXIII Rich X Search. We shall prevail. All rights reserved. Rich X Search